University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Integrilin in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

Mahmoudi, M, Delhaye, C, Wakabayashi, K, Torguson, R, Xue, Z, Suddath, WO, Satler, LF, Kent, KM, Pichard, AD and Waksman, R (2011) Integrilin in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. J Interv Cardiol, 24 (4). pp. 351-356.

Full text not available from this repository.

Abstract

The adjunctive use of eptifibatide in patients undergoing primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) remains controversial. We therefore set out to determine the safety and efficacy of eptifibatide in this population.

Item Type: Article
Authors :
NameEmailORCID
Mahmoudi, Mm.mahmoudi@surrey.ac.uk
Delhaye, C
Wakabayashi, K
Torguson, R
Xue, Z
Suddath, WO
Satler, LF
Kent, KM
Pichard, AD
Waksman, R
Date : August 2011
Identification Number : 10.1111/j.1540-8183.2011.00632.x
Uncontrolled Keywords : Aged, Angioplasty, Balloon, Coronary, Chemotherapy, Adjuvant, Cohort Studies, Female, Humans, Male, Middle Aged, Myocardial Infarction, Peptides, Platelet Aggregation Inhibitors, Registries, Retrospective Studies, Treatment Outcome
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 09:47
Last Modified : 17 May 2017 09:47
URI: http://epubs.surrey.ac.uk/id/eprint/825105

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800